1. Home
  2. ESP vs NGEN Comparison

ESP vs NGEN Comparison

Compare ESP & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Espey Mfg. & Electronics Corp.

ESP

Espey Mfg. & Electronics Corp.

N/A

Current Price

$62.15

Market Cap

186.3M

Sector

Technology

ML Signal

N/A

Logo NervGen Pharma Corp. Common stock

NGEN

NervGen Pharma Corp. Common stock

N/A

Current Price

$1.76

Market Cap

208.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ESP
NGEN
Founded
1928
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
186.3M
208.6M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
ESP
NGEN
Price
$62.15
$1.76
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $11.08
AVG Volume (30 Days)
26.0K
★ 454.0K
Earning Date
09-23-2026
11-14-2026
Dividend Yield
★ 1.63%
N/A
EPS Growth
★ 28.81
N/A
EPS
★ 3.89
N/A
Revenue
★ $46,124,325.00
N/A
Revenue This Year
$13.61
N/A
Revenue Next Year
$5.53
N/A
P/E Ratio
$16.63
★ N/A
Revenue Growth
★ 4.95
N/A
52 Week Low
$36.00
$1.58
52 Week High
$74.77
$5.93

Technical Indicators

Market Signals
Indicator
ESP
NGEN
Relative Strength Index (RSI) 44.70 40.39
Support Level $60.47 $1.85
Resistance Level $67.31 $2.32
Average True Range (ATR) 2.53 0.12
MACD -0.26 -0.04
Stochastic Oscillator 33.73 4.08

Price Performance

Historical Comparison
ESP
NGEN

About ESP Espey Mfg. & Electronics Corp.

Espey Manufacturing & Electronics Corp is a power electronics design and OEM manufacturing company delivering products for military and severe environment applications. Its products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power. Espey services include design and development to specification, build to specifications provided by the customer, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment.

About NGEN NervGen Pharma Corp. Common stock

NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.

Share on Social Networks: